Home Newsfeeds Crypto Giant Genesis To File For Bankruptcy

Crypto Giant Genesis To File For Bankruptcy

https://www.bloomberg.com/news/articles/2023-01-18/crypto-firm-genesis-said-to-prepare-bankruptcy-filing-as-soon-as-this-week

byBenzinga Newsdesk

January 18, 2023

1 minute read

https://www.bloomberg.com/news/articles/2023-01-18/crypto-firm-genesis-said-to-prepare-bankruptcy-filing-as-soon-as-this-week

Researchers Confirm: iPhone Is A Secure Device, Puts NSO Spyware To Shame By Blocking Hack Attempts

By Anusuya Lahiri

April 19, 8:15 AM

Citizen Lab researchers lauded Apple Inc (NASDAQ:AAPL) iPhone’s Lockdown Mode feature for defending against notorious NSO Group spyware. In 2022, Apple…

AAPL

Liberty Latin America Q3 EPS $0.38 Up From $0.33 YoY, Sales $1.22B Beat $1.21B Estimate

By Benzinga Newsdesk

November 8, 6:28 PM

Liberty Latin America (NASDAQ:LILA) reported quarterly earnings of $0.38 per share. This is a 15.15 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales

LILA

News

WiSA Technologies Issues Letter To Shareholders

By Benzinga Newsdesk

April 26, 8:38 AM

I am writing to share some exciting news regarding WiSA Technologies and our upcoming Special Meeting of Stockholders on May 13, 2024.At its core, WiSA Technologies is an innovative company, a company whose dynamic

WISA

Jasper Therapeutics Announces Preclinical Data Presentations At American Academy of Allergy, Asthma, and Immunology Annual Meeting

By Benzinga Newsdesk

February 5, 9:11 AM

etails of the presentations are as follows:Abstract Title: Briquilimab, An Anti-CD117 Antibody, Prevents Passive Systemic Anaphylaxis in Mice Expressing Chimeric Human and Mouse CD117 Through Mast Cell

JSPR

Crypto Giant Genesis To File For Bankruptcy

Related Posts

Researchers Confirm: iPhone Is A Secure Device, Puts NSO Spyware To Shame By Blocking Hack Attempts

Liberty Latin America Q3 EPS $0.38 Up From $0.33 YoY, Sales $1.22B Beat $1.21B Estimate

WiSA Technologies Issues Letter To Shareholders

Jasper Therapeutics Announces Preclinical Data Presentations At American Academy of Allergy, Asthma, and Immunology Annual Meeting